Grupo Español de Tumores Huérfanos e Infrecuentes

Grupo Español de Tumores Huérfanos e Infrecuentes (GETHI) is a Spanish non-profit scientific association dedicated to the research and clinical management of rare and orphan tumors. Founded in 2012, the organization operates as a cooperative group that facilitates multicenter clinical trials and translational research across Spain to address malignancies with low prevalence. GETHI focuses on improving diagnosis and therapeutic outcomes by identifying actionable molecular drivers through genomic profiling and patient registries. The group fosters collaboration between oncologists, pathologists, and the pharmaceutical industry to accelerate access to targeted therapies for patients who often lack dedicated treatment options. Their portfolio includes significant basket trials investigating inhibitors for targets such as NTRK and RET in rare cancer populations.